NCT02243891
AF Ablation With or Without ROX Coupler Study
Left Atrial Ablation for Paroxysmal Atrial Fibrillation and Hypertension With Implantable Loop Recorder With or Without ROX Coupler Follow Up Study: The LAAPITUP 3 Study
Neil Sulke·Phase 4·ClinicalTrials.gov·procedure
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Atrial Fibrillation,Hypertension
- Drug/Device/Intervention
- Atrial fibrillation ablation
- Study type
- Interventional
- Intervention type
- procedure
Sponsor & location
- Primary sponsor
- Neil Sulke
- Funder
- Eastbourne General Hospital
- Location
- Eastbourne, United Kingdom
Timeline & enrollment
- Phase
- Phase 4
- Start date
- May 01, 2015
- End date
- Oct 01, 2017
- Enrollment
- 40 participants
Primary outcome
AF ablation success
Summary
The study will test the hypothesis that ablation of paroxysmal atrial fibrillation in
 hypertensive subjects is more effective when a ROX coupler is inserted concurrently.
ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT02243891
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT02243891 through Pure Global AI's free database. This Phase 4 trial is sponsored by Neil Sulke and is currently status unknown. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.